Högskolan i Skövde

his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Innovative intraoral cooling device better tolerated and equally effective as ice cooling
Department of Oral Medicine & Pathology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
University West, School of Business, Economics and IT, University West, Trollhättan, Sweden.ORCID iD: 0000-0002-0575-4309
Department of Hematology, Institute for Medical Sciences, Faculty of Medicine, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
Department of Oral Medicine & Pathology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
2017 (English)In: Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, E-ISSN 1432-0843, Vol. 80, no 5, p. 965-972Article in journal (Refereed) Published
Abstract [en]

PURPOSE: Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake and result in weight loss, a need for parenteral nutrition, and impaired quality of life. To date, there have been very few studies of evidence-based interventions for the prevention of OM. Cryotherapy, using ice chips, has been shown to reduce in an efficient manner the severity and extent of OM, although clinical applications are still limited due to several shortcomings, such as adverse tooth sensations, problems with infectious organisms in the water, nausea, and uneven cooling of the oral mucosa. The present proof-of-concept study was conducted to compare the tolerability, temperature reduction, and cooling distribution profiles of an intra-oral cooling device and ice chips in healthy volunteers who did not receive myeloablative treatment, and therefore, did not experience the symptoms of OM.

METHODS: Twenty healthy volunteers used the cooling device and ice chips for a maximum of 60 min each, using a cross-over design. The baseline and final temperatures were measured at eight intra-oral locations using an infra-red thermographic camera. The thermographic images were analysed using two digital software packages. A questionnaire was used to assess the tolerability levels of the two interventions.

RESULTS: The intra-oral cooling device was significantly better tolerated than the ice-chips (p = 0.0118). The two interventions were equally effective regarding temperature reduction and cooling distribution.

CONCLUSIONS: The intra-oral cooling device shows superior tolerability in healthy volunteers. Furthermore, this study shows that temperature reduction and cooling distribution are achieved equally well using either method.

Place, publisher, year, edition, pages
Springer, 2017. Vol. 80, no 5, p. 965-972
Keywords [en]
Cryotherapy, Healthy volunteers, Intra-oral cooling device, Myeloablative therapy, Oral mucositis, Tolerability
National Category
Pharmaceutical Sciences Cancer and Oncology
Research subject
SOCIAL SCIENCE, Informatics
Identifiers
URN: urn:nbn:se:his:diva-20370DOI: 10.1007/s00280-017-3434-2ISI: 000414762300009PubMedID: 28975429Scopus ID: 2-s2.0-85030321787OAI: oai:DiVA.org:his-20370DiVA, id: diva2:1583641
Funder
Region Västra Götaland, VGFOUGSB-607421
Note

CC BY 4.0

Funders: Funders: Blood Cancer Society (2015-10-16); Assar Gabrielsson’s Foundation (FB16-04); Wilhelm and Martina Lundgrens Research fund (2016-0986); Gothenburg Dental Society (2016-10-26); The Local Research and Development Council Södra Älvsborg (VGFOUSA-573821).

This article has a correction:Correction to: Innovative intraoral cooling device better tolerated and equally effective as ice coolinghttp://doi.org/10.1007/s00280-017-3465-8

Available from: 2017-11-23 Created: 2021-08-09

Open Access in DiVA

fulltext(698 kB)108 downloads
File information
File name FULLTEXT01.pdfFile size 698 kBChecksum SHA-512
6087973ef6c8c54fd33338ce721c53afd85df7766ea80e4d1873a54311fb8dce81eb4d25744fee46ff0a15e3f1a52dc2eebe75d8413b36f3f9f4290906c33067
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Gellerstedt, Martin

Search in DiVA

By author/editor
Gellerstedt, Martin
In the same journal
Cancer Chemotherapy and Pharmacology
Pharmaceutical SciencesCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 108 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 67 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf